<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0901233078
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MODODOM 10MG F.C. TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DOMPERIDONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        7.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A03FA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Mododom&nbsp; </strong>contains a medicine called domperidone. This belongs to a group of medicines called &lsquo;dopamine antagonists&rsquo;.</p><p>This medicine is used in adults and in children to treat nausea (feeling sick) and vomiting (being sick).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take </strong><strong>Mododom&nbsp;</strong><strong>if: </strong></p><p>&bull;&nbsp; You are allergic (hypersensitive) to domperidone or any of the other ingredients of <strong>Mododom&nbsp;</strong> (listed in section 6: Contents of the pack and other information). Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.</p><p>&bull;&nbsp; You have a tumour of the pituitary gland (prolactinoma)</p><p>&bull;&nbsp; You have a blockage or tear in your intestines</p><p>&bull;&nbsp; You have black, tarry bowel motions (stools) or notice blood in your bowel motions. This could be a sign of bleeding in the stomach or intestines.</p><p>&bull;&nbsp; You have a moderate or severe liver disease.</p><p>&bull;&nbsp; Your ECG (electrocardiogram) shows a heart problem called &ldquo;prolonged QT corrected interval&rdquo;.</p><p>&bull;&nbsp; You have or had a problem where your heart cannot pump the blood round your body as well as it should (condition called heart failure).</p><p>&bull;&nbsp; You have a problem that gives you a low level of potassium or magnesium, or a high level of potassium in your blood.</p><p>&bull;&nbsp; You are taking certain medicines (see &ldquo;Other medicines and <strong>Mododom&nbsp;</strong>&rdquo;)</p><p>Do not take <strong>Mododom&nbsp;</strong>if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist</p><p>before taking <strong>Mododom</strong>.</p><p><strong>Warnings and precautions</strong></p><p>Before taking this medicine contact your doctor if:</p><p>&bull;&nbsp; You suffer from liver problems (liver function impairment or failure) (see &ldquo;Do not take <strong>Mododom&nbsp;</strong>if&rdquo;)</p><p>&bull;&nbsp; You suffer from kidney problems (kidney function impairment or failure). It is advisable to ask your doctor</p><p>for advice in case of prolonged treatment as you may need to take a lower dose or take this medicine less</p><p>often, and your doctor may want to examine you regularly.</p><p>If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking <strong>Mododom</strong>.</p><p>Do this even if they have applied in the past.</p><p>Domperidone may be associated with an increased risk of heart rhythm disorder and cardiac arrest. This risk may be more likely in those over 60 years old or taking doses higher than 30 mg per day. The risk also increases when <strong>Mododom&nbsp;</strong>is given together with some drugs. Tell your doctor or pharmacist if you are taking drugs to treat infection (fungal infections or bacterial infection) and/or if you have heart problems or AIDS/HIV (see &ldquo;Other medicines and <strong>Mododom&nbsp;</strong>).</p><p><strong>Mododom&nbsp;</strong> should be used at the lowest effective dose in adults and children.</p><p>While taking <strong>Mododom&nbsp;</strong>, contact your doctor if you experience heart rhythm disorders such as palpitations,</p><p>trouble breathing, loss of consciousness. Treatment with <strong>Mododom&nbsp;</strong>should be stopped.</p><p><strong>Other medicines and </strong><strong>Mododom&nbsp;</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes medicines you can buy without a prescription, including herbal medicines. This is because <strong>Mododom&nbsp;</strong> can affect the way some other medicines work. Also, some medicines can affect the way <strong>Mododom&nbsp;</strong> works.</p><p><strong>Do not take </strong><strong>Mododom&nbsp;</strong><strong> if you are taking medicine to treat:</strong></p><p>&bull;&nbsp; Fungal infections such as azole anti-fungals, specifically oral ketoconazole, fluconazole or voriconazole.</p><p>&bull;&nbsp; Bacterial infections, specifically erythromycin, clarithromycin, telithromycin, moxifloxacin, pentamidine (these are antibiotics)</p><p>&bull;&nbsp; Heart problems or high blood pressure (e.g., amiodarone, dronedarone, quinidine, disopyramide, dofetilide, sotalol, diltiazem, verapamil)</p><p>&bull;&nbsp; Psychoses (e.g., haloperidol, pimozide, sertindole)</p><p>&bull;&nbsp; Depression (e.g., citalopram, escitalopram)</p><p>&bull;&nbsp; Gastro-intestinal disorders (e.g., cisapride, dolasetron, prucalopride)</p><p>&bull;&nbsp; Allergy (e.g., mequitazine, mizolastine)</p><p>&bull;&nbsp; Malaria (in particular halofantrine)</p><p>&bull;&nbsp; AIDS/HIV (protease inhibitors)</p><p>&bull;&nbsp; Cancer (e.g., toremifene, vandetanib, vincamine)</p><p>Tell your doctor or pharmacist if you are taking drugs to treat infection, heart problems or AIDS/HIV.</p><p><strong><u>Mododom&nbsp;</u></strong><strong><u> and apomorphine</u></strong></p><p>Before you use <strong>Mododom&nbsp;</strong> and apomorphine, your doctor will ensure that you tolerate both medicines when used simultaneously. Ask your doctor or specialist for a personalised advice. It is important to ask your doctor or pharmacist if <strong>Mododom&nbsp;</strong> is safe for you when you are taking any other medicines, including medicines obtained without prescription.</p><p><strong>Taking </strong><strong>Mododom&nbsp;</strong> <strong>with food and drink </strong></p><p>It is recommended to take <strong>Mododom&nbsp;</strong> before meals, as when taken after meals the absorption of the medicine is slightly delayed.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>Talk to your doctor or pharmacist before taking <strong>Mododom&nbsp;</strong> if:</p><p>&bull;&nbsp; You are pregnant, might become pregnant or think you may be pregnant</p><p>&bull;&nbsp; You are breast-feeding. It is best not to take <strong>Mododom&nbsp;</strong> if you are breast-feeding.</p><p>Small amounts of Domperidone have been detected in breast-milk. Domperidone may cause unwanted side effects affecting the heart in a breast-fed baby. <strong>Mododom&nbsp;</strong> should be used during breast feeding only if your physician considers this clearly necessary. Ask your doctor for advice before taking this medicine.</p><p><strong>Driving and using machines:</strong></p><p>Domperidone does not affect your ability to drive or use machines.</p><p><strong>Important information about some of the ingredients of </strong><strong>Mododom&nbsp;</strong></p><p>This medicine contains lactose. If you have been told that you cannot digest or tolerate some sugars, talk to</p><p>your doctor before taking <strong>Mododom&nbsp;</strong>.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Follow these instructions closely unless your doctor has advised you otherwise. You should check with your doctor or pharmacist if you are not sure.</p><p><strong>Duration of treatment</strong></p><p>Your doctor will decide how long you will need to take this medicine.</p><p>Symptoms usually resolve with 3-4 days of taking this medicine. Do not take <strong>Mododom&nbsp;</strong>for longer than 7 days without consulting your doctor.<strong> </strong></p><p><strong>Taking this medicine</strong></p><p>&bull;&nbsp; Swallow the tablets whole with a drink of water.</p><p>&bull;&nbsp; Take the tablets 15 to 30 minutes before a meal.</p><p>&bull;&nbsp; Do not crush or chew them.</p><p><strong>The usual dose is:</strong></p><p>&bull;&nbsp; <strong><u>Adults and adolescents 12 years of age and older with a body weight of 35kg or more</u></strong></p><p>The usual dose is one tablet (10mg) taken up to three times per day, if possible before meals. Do not take more<u> </u>than three tablets (30mg) per day.</p><p><u>&nbsp;</u></p><p>&bull;&nbsp; <strong><u>Children and adolescents from birth to a body weight of less than 35kg</u></strong></p><p><strong>Mododom</strong> tablets are not suitable for children weighing less than 35kg. If domperidone<strong> </strong>is for a child, ask your doctor for the children&rsquo;s formulation.</p><p><strong>People with kidney problems</strong></p><p>Your doctor may tell you to take a lower dose or to take the medicine less often.</p><p><strong>If you take more Mododom</strong> <strong>than you should</strong></p><p>&bull;&nbsp; If you have used or taken too many <strong>Mododom</strong> tablets contact your doctor, pharmacist or your nearest hospital casualty department immediately, in particular if a child has taken too much. Take the carton and any tablets left with you. This is so the doctors know what you have taken.</p><p>In the event of overdose, symptomatic treatment could be implemented. An ECG monitoring could be undertaken, because of the possibility of a heart problem called prolonged QT interval.</p><p>&bull;&nbsp; The signs of taking more than you should include feeling sleepy, confused, uncontrolled movements (especially in children) which include unusual eye movements, unusual movements of the tongue or abnormal posture (such as a twisted neck).</p><p><strong>If you forget to take Mododom</strong></p><p>&bull;&nbsp; If you forget to take <strong>Mododom</strong>, take it as soon as you remember.</p><p>&bull;&nbsp; However if it is almost time for the next dose, wait until that is due and then continue as normal.</p><p>&bull;&nbsp; Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you have any further questions on the use of this medicaine, ask your doctor or pharmacist.</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <strong>Mododom</strong> can cause side effects although not everybody gets them.</p><p><strong>Stop taking </strong><strong>Mododom</strong> <strong>and see your doctor or go to a hospital straightaway if:</strong></p><p>&bull;&nbsp; You get swelling of the hands, feet, ankles, face, lips or throat which may cause difficulty in swallowing or breathing. You could also notice an itchy, lumpy rash (hives) or nettle rash (urticaria). This may mean you are having an allergic reaction to domperidone.</p><p>&bull;&nbsp; You notice any uncontrolled movements. These include irregular eye movements, unusual movements of the tongue, and abnormal posture such as a twisted neck, trembling and muscle stiffness. This is more likely to happen in children. These symptoms should stop once you stop taking <strong>Mododom</strong>.</p><p>&bull;&nbsp; You have a very fast or unusual heartbeat. This could be a sign of a life-threatening heart problem.</p><p>&bull;&nbsp; You have a fit (seizure).</p><p><strong>Other side effects include:</strong></p><p><strong>Common (affects less than 1 in 10 people)</strong></p><p>&bull;&nbsp; Dry mouth</p><p><strong>Uncommon (affects less than 1 in 1,00 people)</strong></p><p>&bull;&nbsp; Lowering of sexual drive (libido) in men</p><p>&bull;&nbsp; Feeling anxious</p><p>&bull;&nbsp; Feeling drowsy</p><p>&bull;&nbsp; Headaches</p><p>&bull;&nbsp; Diarrhoea</p><p>&bull;&nbsp; Itchy skin. You may also have a rash</p><p>&bull;&nbsp; Unusual production of breast milk in men and women</p><p>&bull;&nbsp; Painful or tender breasts</p><p>&bull;&nbsp; A general feeling of weakness</p><p><strong>Not known (Frequency cannot be estimated from the available data)</strong></p><p>&bull;&nbsp; Disorders of the cardiovascular system: heart rhythm disorders (rapid or irregular heart beat) have been reported; if this happens, you should stop the treatment immediately. Domperidone may be associated with an increased risk of heart rhythm disorder and cardiac arrest. This risk may be more likely in those over 60 years old or taking doses higher than 30 mg per day. <strong>Mododom</strong> should be used at the lowest effective dose in adults and children.</p><p>&bull;&nbsp; Feeling agitated or irritable</p><p>&bull;&nbsp; Feeling more nervous than usual</p><p>&bull;&nbsp; Abnormal eye movements</p><p>&bull;&nbsp; Inability to urinate</p><p>&bull;&nbsp; Breast enlargement in men</p><p>&bull;&nbsp; In women, menstrual periods may be irregular or stop</p><p>&bull;&nbsp; A blood test shows changes in the way your liver is working.</p><p>Some patients who have used domperidone for conditions and dosages requiring longer term medical supervision have experienced the following unwanted effects:</p><p>Restlessness; swollen or enlarged breasts, unusual discharge from breasts, irregular menstrual periods in women, difficulty breastfeeding, depression, hypersensitivity.</p><p>Side effects such as feeling drowsy, nervous, agitated or irritable or having a fit are more likely to happen in children.</p><p><strong>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not</strong><strong> </strong><strong>listed in this leaflet.</strong></p><p><strong><u>To report any side effect(s): </u></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Center (NPC)</strong></p><p><strong>Fax</strong>: +966-11-205-7662</p><p><strong>Call NPC</strong> <strong>at </strong>+966-11-2038222,</p><p><strong>Exts</strong>: 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone</strong>: 8002490000</p><p><strong>E-mail</strong>: npc.drug@sfda.gov.sa</p><p><strong>Website</strong>: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not take <strong>Mododom</strong> after the expiry date which is stated on the carton and on the blister.</p><p>-&nbsp; Store below 30<sup>&deg;</sup>C.</p><p>-&nbsp; Do not take <strong>Mododom</strong> if you notice any visible sign of deterioration.</p><p>-&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Each film-coated tablet contains:</p><p><em>Active ingredient</em>:&nbsp;&nbsp; &nbsp;&nbsp;Domperidone (as maleate)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10mg&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10mg</p><p><em>Other ingredients</em>:&nbsp;&nbsp; Starch, povidone, lactose monohydrate, croscarmellose sodium, microcrystalline cellulose, magnesium stearate, sodium lauryl sulphate, talc, hypromellose, polyethylene glycol and titanium dioxide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Mododom film-coated tablets are available in packs of 20 tablets each.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                28/02/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي <strong>مودودوم </strong>على المادة الفعالة دومبيريدون التي تنتمي إلى مجموعة من الأدوية تعرف باسم مضادات الدوبامين.<strong> </strong></p><p>يستعمل&nbsp; هذا الدواء لعلاج حالات الغثيان (الشعور بالإعياء) والتقيؤ (التوعك) لدى المرضى البالغين والأطفال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>يجب عليك عدم تناول مودودوم في الحالات التالية:</strong></p><p>&bull;&nbsp; إذا كنت تعاني من الحساسية (فرط الحساسية) تجاه دومبيريدون أو تجاه أياً من المكونات الأخرى في<strong> مودودوم </strong>(المذكورة في البند رقم 6: معلومات إضافية) . تتضمن علامات التفاعلات التحسسية على: طفح جلدي، مشاكل في البلع أو التنفس، تورم الشفتين، الوجه، الحلق أو اللسان.</p><p>&bull;&nbsp; إذا كنت تعاني من ورم الغدة النخامية (ورم برولاكتيني).</p><p>&bull;&nbsp; إذا عانيت من انسداد أو انثقاب الأمعاء.</p><p>&bull;&nbsp; اسوداد لون البراز أو ملاحظة وجود دم في البراز. قد يكون ذلك الأمر علامة على حدوث نزيف في المعدة أو الأمعاء.</p><p>&bull;&nbsp; إذا كنت تعاني من اضطراب معتدل أو شديد في الكبد.</p><p>&bull;&nbsp; إذا كنت تعاني من اضطراب في القلب &quot; إطالة الزمن الفاصل بين موجات كيو تي&quot; الذي يكشف عنه بواسطة تخطيط كهربائية القلب.</p><p>&bull;&nbsp; إذا كنت تعاني من أو عانيت مسبقاً من مشكلة تتمثل بعدم قدرة القلب على ضخ الدم إلى أنحاء الجسم&nbsp; بكفاءة.</p><p>&bull;&nbsp; إذا كنت تعاني من حالة مرضية تتسبب في انخفاض مستوى البوتاسيوم أو المغنيسيوم، أو ارتفاع مستوى البوتاسيوم في الدم.</p><p>&bull;&nbsp; إذا كنت تتلقى علاج باستخدام أدوية معينة (انظر &quot;تناول الأدوية الأخرى بالتزامن مع <strong>مودودوم</strong>&quot;</p><p>يجب عليك عدم تناول <strong>مودودوم</strong> إذا كان أياً مما سبق ينطبق عليك. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>مودودوم</strong>، إذا كان لديك أدنى شك.</p><p><strong>تحذيرات واحتياطات</strong></p><p>يرجى منك التواصل مع طبيبك المعالج قبل تناول هذا الدواء في الحالات التالية:</p><p>&bull;&nbsp; إذا كنت تعاني من مشاكل في الكبد (قصور أو اضطراب في وظائف الكبد) (انظر &quot; يجب عليك عدم تناول <strong>مودودوم </strong>في الحالات التالية&quot;</p><p>&bull;&nbsp; إذا كنت تعاني من مشاكل في الكلى (قصور أو اضطراب في وظائف الكلى). يرجى منك استشارة طبيبك المعالج للحصول على النصيحة في حال كنت تتلقى العلاج لفترة زمنية طويلة، فقد تكون بحاجة إلى تقليل مقدار الجرعة أو تقليل معدل تكرار تناول هذا الدواء، وقد يرغب طبيبك المعالج بإجراء فحوصات لك بصورة منتظمة. &nbsp;</p><p>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>مودودوم</strong>، إذا لم تكن متأكداً أن ما ذكر أعلاه ينطبق عليك، أو حتى وإن عانيت مسبقاً من هذه الحالات.</p><p><strong>&nbsp;</strong>قد يصاحب تناول دومبيريدون زيادة حدوث مخاطر اضطراب نظم ضربات القلب والسكته القلبية. كما قد يكون المرضى بعمر أكبر من 60 سنة أو الذين يتناولون جرعات أعلى من 30 ملغم يومياً أكثر عرضة لحدوث هذه المخاطر. كما يزداد حدوث هذه المخاطر عند تناول<strong> مودودوم </strong>بالتزامن مع بعض الأدوية.</p><p>يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كنت تتناول الأدوية التي تستخدم لعلاج العدوى (العدوى الناجمة عن الفطريات أو البكتيريا) و/أو إذا كنت تعاني من مشاكل في القلب أو فيروس نقص المناعة البشرية المكتسبة (مرض الإيدز) (انظر &quot; تناول الأدوية الأخرى بالتزامن مع <strong>مودودوم</strong>&quot;).</p><p>ينبغي استعمال <strong>مودودوم</strong> بأقل جرعة فعالة في البالغين والأطفال.</p><p>يرجى منك التواصل مع طبيبك المعالج وكما يجب التوقف عن تلقي العلاج باستعمال <strong>مودودوم،</strong> إذا عانيت من اضطرابات في نظم ضربات القلب على سبيل المثال خفقان، صعوبة في التنفس، فقدان الوعي أثناء فترة تناول<strong> مودودوم</strong>.&nbsp;</p><p><strong>تناول الأدوية الأخرى بالتزامن مع </strong><strong>مودودوم </strong></p><p>يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول أو تناولت مؤخراً أية أدوية أخرى، بما في ذلك الأدوية التي تصرف دون وصفة طبية والأدوية العشبية، حيث قد<strong> </strong>يؤثر <strong>مودودوم</strong> على آلية عمل بعض الأدوية الأخرى، كما قد تؤثر بعض الأدوية الأخرى على آلية عمل <strong>مودودوم.</strong></p><p><strong>يجب عليك عدم تناول مودودوم إذا كنت تتناول أياً من الأدوية التي تستعمل لعلاج الحالات الصحية التالية:</strong></p><p>&bull;&nbsp; العدوى الفطرية على سبيل المثال &nbsp;مضادات الفطريات من مجموعة الأزول وبصورة خاصة كيتوكونازول التي يتم تناولها عن طريق الفم ، فلوكونازول أو فوريكونازول.</p><p>&bull;&nbsp; العدوى البكتيرية، بصورة خاصة إريثروميسين، كلاريثروميسين، تيليثروميسين، موكسيفلوكساسين، بينتاميدين (مضادات حيوية).</p><p>&bull;&nbsp; المشاكل القلبية أو ارتفاع ضغط الدم (على سبيل المثال أميودارون، درونيدارون، كوينيدين، دايزوبيراميد، دوفيتيليد، سوتالول، ديلتيازيم، فيراباميل)</p><p>&bull;&nbsp; الذهان (على سبيل المثال، هالوبيريدول، بيموزيد، سرتيندول)</p><p>&bull;&nbsp; الاكتئاب (على سبيل المثال، سيتالوبرام، إسيتالوبرام)</p><p>&bull;&nbsp; الاضطرابات المعدية المعوية (على سبيل المثال، سيسابريد، دولاسيترون، بروكالوبريد)</p><p>&bull;&nbsp; الحساسية (على سبيل المثال، ميكويتازين، ميزولاستين)</p><p>&bull;&nbsp; الملاريا (وبصورة خاصة هالوفانترين)</p><p>&bull;&nbsp; مرض الإيدز / فيروس نقص المناعة البشرية المكتسبة (مثبطات الأنزيم البروتيني)</p><p>&bull;&nbsp; السرطان (على سبيل المثال، توريميفين، فانديتانيب، فينكامين)</p><p>يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول أدوية أخرى لعلاج حالات العدوى، مشاكل في القلب أو لعلاج مرض الإيدز / فيروس نقص المناعة البشرية المكتسبة.</p><p><u>استعمال</u><u> <strong>مودودوم</strong> بالتزامن مع</u><u> آبومورفين</u></p><p>قبل تلقي العلاج باستخدام&nbsp; <strong>مودودوم</strong> وآبومورفين، سوف يتأكد طبيبك المعالج من مدى قدرة تحملك عند استعمال <strong>مودودوم</strong> بالتزامن مع آبومورفين. يرجى منك استشارة طبيبك أو ممارسي الرعاية الصحية &nbsp;للحصول على النصيحة.</p><p>من المهم استشارة طبيبك المعالج او الصيدلي الذي تتعامل معه من مدى سلامة تناول <strong>مودودوم، </strong>في حال كنت تتناول أية أدوية أخرى بما في ذلك الأدوية التي تصرف دون وصفة طبية.</p><p><strong>تناول مودودوم مع الطعام والشراب</strong></p><p>يوصى بتناول <strong>مودودوم</strong> قبل وجبات الطعام، حيث يؤدي تناوله بعد الوجبات إلى تأخير امتصاص الدواء قليلاً.<strong> </strong></p><p><strong>الحمل </strong><strong>و</strong><strong>الرضاعة الطبيعية</strong></p><p>يرجى منك التحدث إلى طبيبك المعالج او الصيدلي الذي تتعامل معه قبل تناول <strong>مودودوم </strong>في الحالات التالية:</p><p>&bull;&nbsp; إذا كنت حاملاً، تعتقدين أنك قد تكونين حاملاً. أو تخططين لذلك.</p><p>&bull;&nbsp; إذا كنت ترضعين طفلك رضاعة طبيعية. يفضل بعدم تناول <strong>مودودوم </strong>إذا كنت ترضعين طفلك رضاعة طبيعية.</p><p>تفرز كميات ضئيلة من دومبيريدون في حليب الثدي. قد يتسبب دومبيريدون في حدوث تأثيرات جانبية غير مرغوب فيها التي تؤثر على قلب الطفل الرضيع. يجب تناول <strong>مودودوم</strong> أثناء الرضاعة الطبيعية فقط إذا رأى الطبيب المعالج ضرورة لذلك بصورة واضحة. يرجى منك استشارة طبيبك المعالج للحصول على النصيحة قبل تناول هذا الدواء.</p><p><strong>القيادة واستخدام الآلات</strong><strong> </strong></p><p>لا تؤثر مادة الدومبيريدون على قدرتك على القيادة أو استعمال الآلات.</p><p><strong>معلومات هامة عن بعض مكونات مودودوم</strong></p><p>يحتوي هذا الدواء على اللاكتوز. يرجى منك استشارة طبيبك قبل تناول <strong>مودودوم</strong> إذا كان قد أخبرك مسبقاً بأنك تعاني من مشكلة تتمثل في عدم القدرة على تحمل بعض أنواع السكر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يرجى منك اتباع التعليمات المذكورة أدناه ما لم ينصحك الطبيب بخلاف ذلك.&nbsp; يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا لم تكن متأكداً من كيفية تناول هذا الدواء.</p><p><strong>مدة الاستعمال</strong></p><p>سوف يحدد الطبيب المعالج المدة اللازمة لتناول هذا الدواء.</p><p>عادة تتحسن حالة الأعراض في غضون 3 &ndash; 4 أيام من تناول هذا الدواء. يجب عليك عدم تناول <strong>مودودوم </strong>أكثر من 7 أيام دون استشارة طبيبك المعالج.</p><p><strong>حول تناول هذا الدواء</strong></p><p>&bull;&nbsp; يرجى منك ابتلاع القرص كاملاً مع شرب كوباً من الماء.</p><p>&bull;&nbsp; تناول الأقراص قبل وجبات الطعام بحوالي 15 &ndash; 30 دقيقة.</p><p>&bull;&nbsp; يجب عدم سحق أو مضغ الأقراص.<strong>&nbsp;</strong></p><p><strong>مقدار الجرعة الاعتيادية:</strong></p><p><strong><u>البالغون والمراهقون أكبر من 12سنة فما فوق ويزنون 35 كيلوغرام أو أكثر </u></strong></p><p>يبلغ مقدار الاعتيادية بها قرصاً واحداً (10 ملغم) ويتم تناولها حتى ثلاث مرات يومياً، قبل وجبات الطعام إذا أمكن ذلك. يجب عليك عدم تناول أكثر من 3 أقراص (30 ملغم) في اليوم.</p><p><strong><u>المراهقين والأطفال منذ سن الولادة ويزنون أقل من 35 كيلوغرام</u></strong></p><p>لا تلائم أقراص <strong>مودودوم</strong> الأطفال الذين يزنون أقل من 35 كيلوغرام.</p><p>إذا تم وصف دومبيريدون للطفل، يرجى منك&nbsp; استشارة الطبيب المعالج حول الشكل الصيدلاني المناسب للطفل.</p><p><strong>المرضى الذين يعانون من مشاكل في الكلى</strong></p><p>قد يخبرك طبيبك المعالج بتناول أقل مقدار ممكن من الجرعة أو يقلل معدل تكرار تناول الدواء.</p><p><strong>إذا تناولت مودودوم بجرعة أكبر مما يجب </strong></p><p>&bull;&nbsp; يرجى منك التواصل مع طبيبك المعالج، الصيدلي الذي تتعامل معه أو التوجه إلى أقرب مستشفى على الفور مع أخذ عبوة الدواء وأي كمية متبقية من الأقراص، إذا تناولت العديد من أقراص <strong>مودودوم</strong> وبصورة خاصة في حال تناول طفلاً هذا الدواء بجرعة أكبر مما يجب.</p><p>في حالات فرط الجرعة ينبغي اللجوء إلى معالجة الأعراض، كما يجب إخضاع المريض لتخطيط القلب الكهربائي حيث أنه من المحتمل حدوث مشكلة في القلب وهي إطالة الزمن الفاصل بين موجات كيو تي في رسم مخطط كهربية القلب.</p><p>&bull;&nbsp; تتضمن علامات فرط الجرعة على الشعور بالنعاس، الارتباك، عدم التحكم في حركات الجسم (بصورة خاصة لدى الأطفال) والتي تتضمن حركة العين، واللسان بصورة غير معتادة أو حدوث وضعيات غير طبيعية (على سبيل المثال التواء الرقبة).</p><p><strong>إذا سهوت عن تناول هذا مودودوم</strong></p><p>&bull;&nbsp; إذا سهوت عن تناول إحدى جرعات <strong>مودودوم</strong>، فيجب عليك تناولها هذا الدواء في أقرب وقت ممكن حال تذكرها</p><p>&bull;&nbsp; على الرغم من ذلك، في حال اقتراب موعد تناول الجرعة التالية، فيجب عليك الانتظار وتناول الجرعة التالية ومن ثم الاستمرار تناول هذا الدواء كما هو معتاد.</p><p>&bull;&nbsp; يجب عليك عدم مضاعفة مقدار الجرعة لتعويض الجرعة التي قد سهوت عنها.</p><p><strong>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كان لديك أسئلة إضافية حول استعمال هذا الدواء</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو عليه الحال مع جميع الأدوية، قد يتسبب <strong>مودودوم</strong> في حدوث تأثيرات جانبية، بالرغم من ذلك فإنها قد لا تحدث لكل شخص.</p><p><strong>يرجى منك التوقف عن تناول مودودوم والتوجه إلى طبيبك المعالج أو إلى المستشفى على الفور في الحالات التالية</strong><strong>:</strong></p><p>&bull;&nbsp; إذا تعرضت لتورم في اليدين، القدمين، الكاحلين، الوجه، الشفتين أو الحلق الأمر الذي قد يسبب صعوبة في البلع أو التنفس. كما قد تلاحظ حدوث حكة، طفح جلدي على شكل خلايا النحل، أو طفح القراص (شرى). الأمر الذي يشير إلى أنك تعاني من تفاعلات تحسسية تجاه دومبيريدون.</p><p>&bull;&nbsp; إذا لاحظت حدوث حركات لا إرادية والتي تتضمن حركات غير منتظمة في العين، حركات غير معتادة في اللسان وحدوث وضعيات غير طبيعية مثل التواء الرقبة، ارتعاش وتصلب العضلات. يرجح حدوث ذلك غالبا ً لدى الأطفال. يجب أن تتوقف هذه الأعراض بمجرد التوقف عن تناول<strong> مودودوم</strong>.</p><p>&bull;&nbsp; إذا عانيت من تسارع شديد في ضربات القلب أو أصبحت ضربات القلب غير طبيعية. قد يكون هذا الأمر علامة تدل على وجود مشكلة في القلب تهدد الحياة.</p><p>&bull;&nbsp; إذا كنت تعاني من نوبات تشنجية (اختلاجات).</p><p><strong>تتضمن التأثيرات الجانبية الأخرى على:</strong></p><p><strong>شائعة (تؤثر على أقل من شخص واحد من كل 10 أشخاص)</strong></p><p>&bull;&nbsp; جفاف الفم &nbsp;</p><p><strong>غير شائعة (تؤثر على أقل من شخص واحد من كل 100 شخص)</strong></p><p>&bull;&nbsp; فقدان أو فتور في الرغبة الجنسية لدى الرجال</p><p>&bull;&nbsp; الشعور بالقلق</p><p>&bull;&nbsp; الشعور بالنعاس</p><p>&bull;&nbsp; صداع</p><p>&bull;&nbsp; إسهال</p><p>&bull;&nbsp; حكة في الجلد. كما قد يحدث طفح جلدي</p><p>&bull;&nbsp; إفراز حليب الثدي بصورة غير اعتيادية لدى الرجال والنساء</p><p>&bull;&nbsp; الشعور بالألم عند الضغط على الثديين</p><p>&bull;&nbsp; الشعور بالضعف بصورة عامة</p><p><strong>غير معروفة (عدم القدرة على تحديد معدل تكرار حدوثها من البيانات المتاحة)</strong></p><p>&bull;&nbsp; &nbsp;اضطرابات الجهاز القلبي الوعائي:&nbsp; سجل حدوث اضطراب في نظم ضربات القلب (تسارع أو عدم انتظام ضربات القلب)، يجب التوقف عن تلقي العلاج على الفور في حال حدوث ذلك. قد يصاحب تناول دومبيريدون زيادة حدوث مخاطر اضطراب نظم ضربات القلب والسكتة القلبية. كما قد يكون المرضى بعمر أكبر من 60 سنة أو الذين يتناولون جرعات أعلى من 30 ملغم يومياً أكثر عرضة لحدوث هذه المخاطر. ينبغي استعمال <strong>مودودوم</strong> بأقل جرعة فعالة في البالغين والأطفال.</p><p>&bull;&nbsp; الشعور بالانفعال أو الهياج</p><p>&bull;&nbsp; الشعور بالعصبية بصورة غير معتادة</p><p>&bull;&nbsp; حركات غير طبيعية في العين</p><p>&bull;&nbsp; عدم القدرة على التبول</p><p><strong>&bull;&nbsp; </strong>تضخم الثدي لدى الرجال</p><p>&bull;&nbsp; لدى النساء، عدم انتظام أو توقف الدورة الشهرية</p><p>&bull;&nbsp; تظهر فحوصات الدم تغيرات في آلية عمل الكبد</p><p>&nbsp;سجل حدوث التأثيرات الغير مرغوب بها التالية لدى بعض المرضى الذين تلقوا العلاج باستخدام جرعات من دومبيريدون لعلاج حالة مرضية التي تتطلب إشراف طبي طويل الأمد:</p><p>أرق، تورم أو تضخم الثدي، إفرازات غير اعتيادية من الثدي، عدم انتظام الدورة الشهرية لدى النساء، صعوبة في الرضاعة الطبيعية، اكتئاب، فرط الحساسية.</p><p>إن التأثيرات الجانبية على سبيل المثال الشعور بالنعاس، العصبية، الهياج أو الانفعال أو حدوث نوبات تشنجية تعد أكثر حدوثاً لدى الأطفال.</p><p><strong>يرجى منك التحدث إلى طبيبك المعالج، الصيدلي الذي تتعامل معه أو الممرض، في حال حدوث أياً من التأثيرات الجانبية بما في ذلك التأثيرات الجانبية المحتمل حدوثها ولم يتم ذكرها في هذه النشرة.</strong></p><p><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong><br /><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong></p><p><strong>رقم الفاكس: </strong>7662-205-11-966+</p><p><strong>يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على: </strong>2038222-11-966+<strong>&nbsp;<br />وصلة هاتف:</strong>2340-2334-2354-2353-2356-2317</p><p><strong>الهاتف المجاني: </strong>8002490000</p><p><strong>البريد الإلكتروني:</strong><strong> </strong><strong>&nbsp;</strong>npc.drug@sfda.gov.sa</p><p><strong>الموقع الإلكتروني: </strong>www.sfda.gov.sa/npc</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-&nbsp;&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p>-&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>مودودوم</strong> بعد تاريخ انتهاء الصلاحية المذكور على العبوة والشريط.</p><p>-&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30&ordm;م.</p><p>-&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>مودودوم</strong> إذا لاحظت وجود علامات تلف واضحة.</p><p>-&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحتوي كل قرص ذي كسوة على:&nbsp;</p><p>المادة الفعالة:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;دومبيريدون (على هيئة ماليات)&nbsp;&nbsp;&nbsp; 10 ملغم.</p><p>المواد غير الفعالة: &nbsp;نشا، بوفيدون، لاكتوز أحادي الهيدرات، كروس كارميلوز الصوديوم، بلورات السليلوز متناهية الصغر، استيارات المغنيسيوم، سلفات لوريل الصوديوم، تلك، هيبروميلوز، بولي أثيلين جلايكول، ثنائي أكسيد التيتانيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            تتوفر أقراص مودودوم المكسوة في عبوات تحتوي كلاً منها على 20 قرصاً.


        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية &quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            28-02-2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Mododom 10mg Film-coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains:
Item No.	Material Name	Scale (mg/Tab)
		
	Active Ingredient:	
1.		Domperidone Maleate 	12.75
	Equivalent to Domperidone 10mg (appx.)	
		
	Inactive Ingredients:	
1.		Starch (maize starch)	36.75
2.		Povidone (polyvinyl pyrrolidone)	3.00
3.		Lactose monohydrate 	20.00
4.		Sodium lauryl sulphate 	1.00
5.		Croscarmellose sodium (Ac-Di-Sol)	1.00
6.		Microcrystalline cellulose (Avicel)	25.00
7.		Magnesium stearate	0.50
		
	Coating Materials:	
1.		Hypromellose (hydroxypropyl methyl cellulose)	1.70
2.		Polyethylene glycol 	0.30
3.		Titanium dioxide 	0.40
4.		Talc fine powder	0.60

Note: Purified water and Ethanol are used in manufacturing process, which evaporate during drying and do not appear in the final product.

For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated Tablets
Description: White, round biconvex film-coated tablets.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Mododom</strong> is indicated for the relief of the symptoms of nausea and vomiting.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Mododom</strong> should be used at the lowest effective dose for the shortest duration necessary to control nausea and vomiting.</p><p>It is recommended to take oral <strong>Mododom</strong> before meals. If taken after meals, absorption of the drug is somewhat delayed.</p><p>Patients should try to take each dose at the scheduled time. If a scheduled dose is missed, the missed dose should be omitted and the usual dosing schedule resumed. The dose should not be doubled to make up for a missed dose.</p><p>Usually, the maximum treatment duration should not exceed one week.</p><p>See section 4.4. For further information</p><p><strong>Adults and adolescents (12 years of age and older and weighing 35 kg or more)</strong></p><p>One 10mg tablet up to three times per day with a maximum dose of 30 mg per day.</p><p><strong>Neonates, infants, children (less than 12 years of age) and adolescents weighing less than 35 kg</strong></p><p>Due to the need for accurate dosing, <strong>Mododom</strong> tablets are unsuitable for use in children and adolescents weighing less than 35 kg.</p><p><strong><u>Hepatic Impairment</u></strong></p><p>Domperidone is contraindicated in moderate or severe hepatic impairment (see section 4.3). Dose modification in mild hepatic impairment is however not needed (see section 5.2).</p><p><strong><u>Renal Impairment </u></strong></p><p>Since the elimination half-life of domperidone is prolonged in severe renal impairment, on repeated administration, the dosing frequency of domperidone should be reduced to once or twice daily depending on the severity of the impairment, and the dose may need to be reduced. Such patients on prolonged therapy should be reviewed regularly (see sections 4.4 and 5.2)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Domperidone is contraindicated in the following situations:
	Known hypersensitivity to domperidone or any of the excipients
	Prolactin-releasing pituitary tumour (prolactinoma).
	When stimulation of the gastric motility could be harmful e.g. in patients with gastro-intestinal haemorrhage, mechanical obstruction or perforation.
	In patients with moderate or severe hepatic impairment (see section 5.2).
	In patients who have known existing prolongation of cardiac conduction intervals, particularly QTc, patients with significant electrolyte disturbances or underlying cardiac diseases such as congestive heart failure (see section 4.4)
	Co-administration with QT-prolonging drugs, at the exception of apomorphine (see sections 4.4 and 4.5)
	Co-administration with potent CYP3A4 inhibitors (regardless of their QT prolonging effects) (see section 4.5)

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Cardiovascular effects</u></strong></p><p>Domperidone has been associated with prolongation of the QT interval on the electrocardiogram. During post-marketing surveillance, there have been very rare cases of QT prolongation and torsades de pointes in patients taking domperidone. These reports included patients with confounding risk factors; electrolyte abnormalities and concomitant treatment which may have been contributing factors (see section 4.8).</p><p>Epidemiological studies showed that domperidone was associated with an increased risk of serious ventricular arrhythmias or sudden cardiac death (see section 4.8). A higher risk was observed in patients older than 60 years, patients taking daily doses greater than 30 mg, and patients concurrently taking QT-prolonging drugs or CYP3A4 inhibitors.</p><p>Domperidone should be used at the lowest effective dose in adults and children.</p><p>Domperidone is contraindicated in patients with known existing prolongation of cardiac conduction intervals, particularly QTc, in patients with significant electrolyte disturbances (hypokalaemia, hyperkalaemia, hypomagnesaemia), or bradycardia, or in patients with underlying cardiac diseases such as congestive heart failure due to increased risk of ventricular arrhythmia (see section 4.3.). Electrolyte disturbances (hypokalaemia, hyperkalaemia, hypomagnesaemia) or bradycardia are known to be conditions increasing the proarrythmic risk.</p><p>Treatment with domperidone should be stopped if signs or symptoms occur that may be associated with cardiac arrhythmia, and the patients should consult their physician.</p><p>Patients should be advised to promptly report any cardiac symptoms.</p><p><strong><u>Use with apomorphine</u></strong></p><p>Domperidone is contra-indicated with QT prolonging drugs including apomorphine, unless the benefit of the co-administration with apomorphine outweighs the risks, and only if the recommended precautions for co-administration mentioned in the apomorphine SmPC are strictly fulfilled. Please refer to the apomorphine SmPC.</p><p><strong><u>Use in infants</u></strong></p><p>Although neurological side effects are rare (see section 4.8), the risk of neurological side effects is higher in young children since metabolic functions and the blood-brain barrier are not fully developed in the first months of life. Overdosing may cause extrapyramidal symptoms in children, but other causes should be taken into consideration.</p><p><strong><u>Renal impairment</u></strong></p><p>The elimination half-life of domperidone is prolonged in severe renal impairment. For repeated administration, the dosing frequency of domperidone should be reduced to once or twice daily depending on the severity of the impairment. The dose may also need to be reduced.</p><p><strong><u>Excipients</u></strong></p><p>The film-coated tablets contain lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The main metabolic pathway of domperidone is through CYP3A4.&nbsp;<em>In vitro</em>&nbsp;data suggest that the concomitant use of drugs that significantly inhibit this enzyme may result in increased plasma levels of domperidone.</p><p>Increased risk of occurrence of QT-interval prolongation, due to pharmacodynamic and/or pharmacokinetic interactions.</p><p><strong><u>Concomitant use of the following substances is contraindicated</u></strong></p><p>QTc prolonging medicinal products</p><p>&sect; anti-arrhythmics class IA (e.g., disopyramide, hydroquinidine, quinidine)</p><p>&sect; anti-arrhythmics class III (e.g., amiodarone, dofetilide, dronedarone, ibutilide, sotalol)</p><p>&sect; certain anti-psychotics (e.g., haloperidol, pimozide, sertindole)</p><p>&sect; certain anti-depressants (e.g., citalopram, escitalopram)</p><p>&sect; certain antibiotics (e.g. , erythromycin, levofloxacin, moxifloxacin, spiramycin)</p><p>&sect; certain antifungal agents (e.g., pentamidine)</p><p>&sect; certain antimalarial agents (in particular halofantrine, lumefantrine)</p><p>&sect; certain gastro-intestinal medicines (e.g., cisapride, dolasetron, prucalopride)</p><p>&sect; certain antihistaminics (e.g., mequitazine, mizolastine)</p><p>&sect; certain medicines used in cancer (e.g., toremifene, vandetanib, vincamine)</p><p>&sect; certain other medicines (e.g., bepridil, diphemanil, methadone)</p><p>(See section 4.3).</p><p>&sect; apomorphine, unless the benefit of the co-administration outweighs the risks, and only if the recommended precautions for co-administration are strictly fulfilled. Please refer to the apomorphine SmPC.</p><p>Potent CYP3A4 inhibitors (<u>regardless of their QT prolonging effects</u>), i.e.:</p><p>&sect; protease inhibitors</p><p>&sect; systemic azole antifungals</p><p>&sect; some macrolides (erythromycin, clarithromycin, telithromycin)</p><p>(See section 4.3).</p><p><strong><u>Concomitant use of the following substances is not recommended</u></strong></p><p>Moderate CYP3A4 inhibitors i.e. diltiazem, verapamil and some macrolides.</p><p>(See section 4.3)</p><p><strong><u>Concomitant use of the following substances requires caution in use</u></strong></p><p>Caution with bradycardia and hypokalaemia-inducing drugs, as well as with the following macrolides involved in QT-interval prolongation: azithromycin and roxithromycin (clarithromycin is contra-indicated as it is a potent CYP3A4 inhibitor).</p><p>The above list of substances is representative and not exhaustive.</p><p>Separate&nbsp;<em>in vivo pharmacokinetic/pharmacodynamic&nbsp;</em>interaction studies with oral ketoconazole or oral erythromycin in healthy subjects confirmed a marked inhibition of domperidone&#39;s CYP3A4 mediated first pass metabolism by these drugs.</p><p>With the combination of oral domperidone 10mg four times daily and ketoconazole 200mg twice daily, a mean QTc prolongation of 9.8 msec was seen over the observation period, with changes at individual time points ranging from 1.2 to 17.5 msec. With the combination of domperidone 10mg four times daily and oral erythromycin 500mg three times daily, mean QTc over the observation period was prolonged by 9.9 msec, with changes at individual time points ranging from 1.6 to 14.3 msec. Both the Cmax and AUC of domperidone at steady state were increased approximately three-fold in each of these interaction studies. In these studies domperidone monotherapy at 10mg given orally four times daily resulted in increases in mean QTc of 1.6 msec (ketoconazole study) and 2.5 msec (erythromycin study), while ketoconazole monotherapy (200mg twice daily) led to increases in QTc of 3.8 and 4.9 msec, respectively, over the observation period.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy</u></strong></p><p>There are limited post-marketing data on the use of domperidone in pregnant women. Studies in animals have shown reproductive toxicity at maternally toxic doses (see section 5.3). Domperidone should only be used during pregnancy when justified by the anticipated therapeutic benefit.</p><p><strong><u>Breast-feeding</u></strong></p><p>Domperidone is excreted in human milk and breast-fed infants receive less than 0.1 % of the maternal weight-adjusted dose. Occurrence of adverse effects, in particular cardiac effects cannot be excluded after exposure via breast milk. A decision should be made whether to discontinue breast-feeding or to discontinue/abstain from domperidone therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman. Caution should be exercised in case of QTc prolongation risk factors in breast-fed infants.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Domperidone has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Tabulated list of adverse reactions</u></strong></p><p>The safety of domperidone was evaluated in clinical trials and in post-marketing experience. The clinical trials included 1275 patients with dyspepsia, gastro-oesophageal reflux disorder (GORD), Irritable Bowel Syndrome (IBS), nausea and vomiting or other related conditions in 31 double-blind, placebo-controlled studies. All patients were at least 15 years old and received at least one dose of Domperidone (domperidone base). The median total daily dose was 30 mg (range 10 to 80 mg), and median duration of exposure was 28 days (range 1 to 28 days). Studies in diabetic gastroparesis or symptoms secondary to chemotherapy or parkinsonism were excluded.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>The following terms and frequencies are applied:</p><p>Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000), Where frequency cannot be estimated from clinical trials data, it is recorded as &ldquo;Not known&rdquo;.</p><table border="1" cellspacing="0" cellpadding="0" style="width:708px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td colspan="3" style="vertical-align:top"><p><strong>Adverse Drug Reaction</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p></td><td style="vertical-align:top"><p><strong>Not known</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Anaphylactic reaction (including anaphylactic shock)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Loss of libido</p><p>Anxiety</p></td><td style="vertical-align:top"><p>Agitation</p><p>Nervousness</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Somnolence</p><p>Headache</p></td><td style="vertical-align:top"><p>Convulsion</p><p>Extrapyramidal disorder</p></td></tr><tr><td style="vertical-align:top"><p><strong>Eye disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Oculogyric crisis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Cardiac disorders (see section 4.4)</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Ventricular arrhythmias</p><p>Sudden cardiac death</p><p>QTc prolongation</p><p>Torsade de Pointes</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td><td style="vertical-align:top"><p>Dry mouth</p></td><td style="vertical-align:top"><p>Diarrhoea</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorder</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rash</p><p>Pruritus</p></td><td style="vertical-align:top"><p>Urticaria</p><p>Angioedema</p></td></tr><tr><td style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Urinary retention</p></td></tr><tr><td style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Galactorrhoea</p><p>Breast pain</p><p>Breast tenderness</p></td><td style="vertical-align:top"><p>Gynaecomastia</p><p>Amenorrhoea</p></td></tr><tr><td style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Asthenia</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Investigations</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Liver function test abnormal</p><p>Blood prolactin increased</p></td></tr></tbody></table><p>In 45 studies where domperidone was used at higher dosages, for longer duration and for additional indications including diabetic gastroparesis, the frequency of adverse events (apart from dry mouth) was considerably higher. This was particularly evident for pharmacologically predictable events related to increased prolactin. In addition to the reactions listed above, akathisia, breast discharge, breast enlargement, breast swelling, depression, hypersensitivity, lactation disorder, and irregular menstruation were also noted.</p><p><strong><u>Paediatric population</u></strong></p><p>Extrapyramidal disorder occurs primarily in neonates and infants</p><p>Other central nervous system-related effects of convulsionand agitation alsoare primarily reported in infants and children.</p><p>&nbsp;</p><p><strong><u>To report any side effect(s):</u></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Symptoms</u></strong></p><p>Overdose has been reported primarily in infants and children. Symptoms of overdosage may include agitation, altered consciousness, convulsions, disorientation, somnolence and extrapyramidal reactions.</p><p><strong><u>Treatment</u></strong></p><p>There is no specific antidote to domperidone, but in the event of overdose, standard symptomatic treatment should be given immediately. Gastric lavage as well as the administration of activated charcoal may be useful. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation. Close medical supervision and supportive therapy is recommended.</p><p>Anticholinergic, anti-parkinson drugs may be helpful in controlling the extrapyramidal reactions.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> Propulsives, ATC code: A03F A 03</p><p><strong><u>Mechanism of action</u></strong></p><p>Domperidone is a dopamine antagonist with anti-emetic properties, Domperidone does not readily cross the blood-brain barrier. In domperidone users, especially in adults, extrapyramidal side effects are very rare, but domperidone promotes the release of prolactin from the pituitary. Its anti-emetic effect may be due to a combination of peripheral (gastrokinetic) effects and antagonism of dopamine receptors in the chemoreceptor trigger zone, which lies outside the blood-brain barrier in the area postrema. Animal studies, together with the low concentrations found in the brain, indicate a predominantly peripheral effect of domperidone on dopamine receptors.</p><p>Studies in man have shown oral domperidone to increase lower oesophaegeal pressure, improve antroduodenal motility and accelerate gastric emptying. There is no effect on gastric secretion.</p><p>In accordance with ICH&mdash;E14 guidelines, a thorough QT study was performed. This study included a placebo, an active comparator and a positive control and was conducted in healthy subjects with up to 80 mg per day 10 or 20 mg administered 4 times a day of domperidone. This study found a maximal difference of QTc between domperidone and placebo in LS-means in the change from baseline of 3.4 msec for 20 mg domperidone administered 4 times a day on Day 4. The 2-sided 90 % CI (1.0 to 5.9 msec) did not exceed 10 msec. No clinically relevant QTc effects were observed in this study when domperidone was administered at up to 80 mg/day (i.e., more than twice the maximum recommended dosing).</p><p>However, two previous drug-drug interaction studies showed some evidence of QTc prolongation when domperidone was administered as monotherapy (10 mg 4 times a day).The largest time-matched mean difference of QTcF between domperidone and placebo was 5.4 msec (95 % CI: -1.7 to 12.4) and 7.5 msec (95 % CI: 0.6 to 14.4), respectively.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Absorption</u></strong></p><p>Domperidone is rapidly absorbed after oral administration, with peak plasma concentrations occurring at approximately 1hr after dosing. The Cmax and AUC values of domperidone increased proportionally with dose in the 10 mg to 20 mg dose range. A 2- to 3-fold accumulation of domperidone AUC was observed with repeated four times daily (every 5 hr) dosing of domperidone for 4 days.</p><p>The low absolute bioavailability of oral domperidone (approximately 15%) is due to an extensive first-pass metabolism in the gut wall and liver. Although domperidone&#39;s bioavailability is enhanced in normal subjects when taken after a meal, patients with gastro-intestinal complaints should take domperidone 15-30 minutes before a meal. Reduced gastric acidity impairs the absorption of domperidone. Oral bioavailability is decreased by prior concomitant administration of cimetidine and sodium bicarbonate. The time of peak absorption is slightly delayed and the AUC somewhat increased when the oral drug is taken after a meal.</p><p><strong><u>Distribution</u></strong></p><p>Oral domperidone does not appear to accumulate or induce its own metabolism; a peak plasma level after 90 minutes of 21 ng/ml after two weeks oral administration of 30 mg per day was almost the same as that of 18 ng/ml after the first dose. Domperidone is 91-93% bound to plasma proteins. Distribution studies with radiolabelled drug in animals have shown wide tissue distribution, but low brain concentration. Small amounts of drug cross the placenta in rats.</p><p><strong><u>Metabolism</u></strong></p><p>Domperidone undergoes rapid and extensive hepatic metabolism by hydroxylation and N-dealkylation.&nbsp;<em>In vitro&nbsp;</em>metabolism experiments with diagnostic inhibitors revealed that CYP3A4 is a major form of cytochrome P-450 involved in the N-dealkylation of domperidone, whereas CYP3A4, CYP1A2 and CYP2E1 are involved in domperidone aromatic hydroxylation.</p><p><strong><u>Excretion</u></strong></p><p>Urinary and faecal excretions amount to 31 and 66% of the oral dose respectively. The proportion of the drug excreted unchanged is small (10% of faecal excretion and approximately 1% of urinary excretion). The plasma half-life after a single oral dose is 7-9 hours in healthy subjects but is prolonged in patients with severe renal insufficiency.</p><p><strong>Hepatic impairment</strong></p><p>In subjects with moderate hepatic impairment (Pugh score 7 to 9, Child-Pugh rating B), the AUC and C<sub>max</sub>&nbsp;of domperidone is 2.9- and 1.5-fold higher, respectively, than in healthy subjects. The unbound fraction is increased by 25%, and the terminal elimination half-life is prolonged from 15 to 23 hours. Subjects with mild hepatic impairment have a somewhat lower systemic exposure than healthy subjects based on C<sub>max</sub>&nbsp;and AUC, with no change in protein binding or terminal half-life. Subjects with severe hepatic impairment were not studied. Domperidone is contraindicated in patients with moderate or severe hepatic impairment (see section 4.3).</p><p><strong>Renal impairment</strong></p><p>In subjects with severe renal insufficiency (creatinine clearance &lt;30ml/min/1.73m<sup>2</sup>) the elimination half-life of domperidone is increased from 7.4 to 20.8 hours, but plasma drug levels are lower than in healthy volunteers. Since very little unchanged drug (approximately 1%) is excreted&nbsp;<em>via</em>&nbsp;the kidneys, it is unlikely that the dose of a single administration needs to be adjusted in patients with renal insufficiency.</p><p>However, on repeated administration, the dosing frequency should be reduced to once or twice daily depending on the severity of the impairment, and the dose may need to be reduced.</p><p><strong>Paediatric population</strong></p><p>No pharmacokinetic data are available in the paediatric population.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Electrophysiological&nbsp;<em>in vitro</em>&nbsp;and&nbsp;<em>in vivo</em>&nbsp;studies indicate an overall moderate risk of domperidone to prolong the QT interval in humans. In&nbsp;<em>in vitro</em>&nbsp;experiments on isolated cells transfected with hERG and on isolated guinea pig myocytes, exposure ratios ranged between 26- 47-fold, based on IC50 values inhibiting currents through IKr ion channels in comparison to the free plasma concentrations in humans after administration of the maximum daily dose of 10 mg administered 3 times a day. Safety margins for prolongation of action potential duration in&nbsp;<em>in vitro</em>&nbsp;experiments on isolated cardiac tissues exceeded the free plasma concentrations in humans at maximum daily dose (10 mg administered 3 times a day) by 45-fold. Safety margins in&nbsp;<em>in vitro</em>&nbsp;pro-arrhythmic models (isolated Langendorff perfused heart) exceeded the free plasma concentrations in humans at maximum daily dose (10 mg administered 3 times a day) by 9- up to 45-fold. In&nbsp;<em>in vivo</em>&nbsp;models the no effect levels for QTc prolongation in dogs and induction of arrhythmias in a rabbit model sensitized for torsade de pointes exceeded the free plasma concentrations in humans at maximum daily dose (10 mg administered 3 times a day) by more than 22-fold and 435-fold, respectively. In the anesthetized guinea pig model following slow intravenous infusions, there were no effects on QTc at total plasma concentrations of 45.4 ng/mL, which are 3-fold higher than the total plasma levels in humans at maximum daily dose (10 mg administered 3 times a day). The relevance of the latter study for humans following exposure to orally administered domperidone is uncertain.</p><p>In the presence of inhibition of the metabolism via CYP3A4 free plasma concentrations of domperidone can rise up to 3-fold.</p><p>At a high, maternally toxic dose (more than 40 times the recommended human dose), teratogenic effects were seen in the rat. No teratogenicity was observed in mice and rabbits.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:690px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Inactive Ingredients:</u></strong></p></td></tr><tr><td style="vertical-align:top"><ol><li>Starch (maize starch)</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Povidone (polyvinyl pyrrolidone)</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Lactose monohydrate</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Sodium lauryl sulphate</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Croscarmellose sodium (Ac-Di-Sol)</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Microcrystalline cellulose (Avicel)</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Magnesium stearate</li></ol></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Coating Materials:</u></strong></p></td></tr><tr><td style="vertical-align:top"><ol><li>Hypromellose (hydroxypropyl methyl cellulose)</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Polyethylene glycol</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Titanium dioxide</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Talc fine powder</li></ol></td></tr></tbody></table><p><strong><u>&nbsp;</u></strong></p><p><strong><u>Note</u></strong><strong>: </strong>Purified water and Ethanol are used in manufacturing process, which evaporate during drying and do not appear in the final product.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months from the date of manufacturing.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1x20&rsquo;s tablets in a blister strip, packed in a printed carton along with a leaflet.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street.
Ras Al Khaimah - United Arab Emirates.
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                17. January. 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>